Heart disease is silently claiming more lives in India than ever before, and the numbers are deeply worrying.
In 2022 alone, heart attack cases surged by 12.5%, with 32,457 deaths, up from 28,413 the previous year, according to the National Crime Records Bureau (NCRB) report.
That’s nearly 90 lives lost every single day!
The crisis is made worse by a staggering shortage of specialists. India has just one cardiologist for every 3 lakh people. For patients in smaller towns or rural areas, timely diagnosis often isn’t an option, causing delays that can prove fatal.
That’s the gap Cardiotrack is stepping in to bridge.
Meet Cardiotrack: Heart care without borders
Cardiotrack is a Bengaluru-based healthtech firm working on the platform of Uber Diagnostics Pvt Ltd. The company’s mission is to make advanced cardiac care accessible, affordable, and fast, especially for resource-constrained regions.
Using AI-powered portable ECG devices and telemedicine solutions, Cardiotrack empowers primary care physicians to deliver specialist-level heart assessments. No more long waits or traveling to far-off cities for diagnosis.
Cardiotrack’s approach to reimagine cardiac care
Early detection & prevention
Their 12-lead ECG device enables real-time cardiac monitoring, identifying heart-related issues early before they become serious.
Closing the specialist gap
Through AI-driven diagnostics and teleconsultations, it ensures a proper diagnosis, regardless of the areas where cardiologists are scarce.
Scalability & accessibility
Cardiotrack’s telemedicine-based approach brings cardiac screening to underserved areas, saving lives with the right medical intervention at the right time.
Insurance partnerships
Cardiotrack’s Cardiac Risk Assessment (CRA) test is an insurer-approved alternative to the traditional treadmill test, making heart checks quicker, simpler, and more comfortable for patients..
Cardiotrack’s unique proposition
AI integration
What sets Cardiotrack apart is its AI integration. It merges smart algorithms with portable diagnostic devices to provide accurate results on the spot.
This combination makes diagnostics more accessible and reduces the reliance on traditional, often cumbersome, equipment.
Patient-centric approach
For patients, Cardiotrack offers the convenience of at-home pathology and radiology screening services. With a network spanning over 300 locations in India, equipped with advanced technology, patients receive timely and accurate reports.
That means less travel, faster reports, quicker interventions, and better patient outcomes.
Cardiotrack’s flagship solutions
Theon
An integrated telemedicine platform combining proprietary and third-party IoT-enabled diagnostic devices with modular software for a seamless medical testing experience.
Ethos
An enterprise telehealth operating system that enhances efficiency by integrating the Theon network with external resources.
Portable 12-Lead ECG Unit
A rechargeable, Bluetooth-enabled device with enhanced signal connectivity, seamlessly integrating into the Theon platform.
Cardiac Risk Assessment (CRA) Test
A patented, on-site test approved by reinsurers as an alternative to the traditional Treadmill Test, conducted using Cardiotrack’s proprietary portable ECG unit.
The Cardiotrack Journey: From Idea to Impact
Founded in 2019 by Ashim Roy and Avin Agarwal, Cardiotrack was established to bring accessible cardiac diagnostics to underserved areas. Their vision was to leverage technology to bridge the gap in healthcare delivery, ensuring timely and accurate heart health assessments.
The results speak volumes:
- 3,50,000+ patients screened for early detection.
- 50,000+ at-home screenings for maximum convenience.
- 150+ parameters analyzed per screening for richer insights.
- 7,000+ pin codes and 600+ cities served.
- 1,500+ labs and 100+ doctors in the network.
- 12+ health and life insurance partners onboarded.
Addressing India’s biggest healthcare pain points
With its innovative solutions, Cardiotrack is addressing Indian healthcare’s biggest challenges:
- Accessibility: It brings cardiac care to remote and underserved regions by providing portable diagnostic tools.
- Affordability: Continuous innovation has led to a significant reduction in diagnostic costs.
- Efficiency: Integration of AI ensures rapid and accurate diagnostics, facilitating timely medical interventions.
Cardiotrack’s funding and Investors
In March 2024, Cardiotrack secured $2 million in a pre-Series funding led by angel investor Girish Narasimhan. The funds will fuel expansion, particularly partnerships with insurers and a deeper reach into underserved markets.
Their vision is clear: a future where heart screenings are routine, timely, and accessible, no matter where one lives.
Looking ahead
India’s battle against heart disease can’t be won with hospitals and specialists alone. It needs innovation that can bridge the gap!
Cardiotrack is proving that with the right technology in the right hands, world-class cardiac care doesn’t have to be confined to big cities or big budgets.
By putting AI-powered diagnostics into local clinics and even people’s homes, they’re detecting heart problems earlier. They’re giving millions a fighting chance to live longer, healthier lives.
In a country where every heartbeat counts, Cardiotrack isn’t just saving time. It’s saving hearts.
-By Alkama Sohail and the AHT Team
